Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuria. [PDF]
Chandani HK +4 more
europepmc +1 more source
Molecular characterization of Alkaptonuria in Brazilian patients. [PDF]
Moreno CA +9 more
europepmc +1 more source
Video-Assisted Minimally Invasive Endoscopic Aortic Valve Replacement in a Patient With Alkaptonuria. [PDF]
Origel Romero CA +4 more
europepmc +1 more source
Mechanistic Insights into Tyrosinase-Catalyzed Metabolism of Hydroquinone: Implications for the Etiology of Exogenous Ochronosis and Cytotoxicity to Melanocytes. [PDF]
Ito S +9 more
europepmc +1 more source
Combined alkaptonuria and osteoporosis contributing to chronic back pain. [PDF]
Riegler A, Anand G.
europepmc +1 more source
Lichen planus pigmentosus associated with tamoxifen: clinical presentation and pathophysiological insights. [PDF]
Pérez Cáceres LD +3 more
europepmc +1 more source
Extra-facial Melasma Presenting With Isolated Forearm Involvement in a Male Patient. [PDF]
Allevato DM, Davis T, Hamann D.
europepmc +1 more source
Transcatheter Aortic Valve Implantation in Alkaptonuria-Аssociated Severe Aortic Stenosis: A 2.5-Year Follow-Up Case Report and Literature Review. [PDF]
Kitov S +5 more
europepmc +1 more source
A Rare Diagnosis in a Resource-Limited Setting: Alkaptonuria in a Young Dominican Child. [PDF]
Ortiz Hernández IY +4 more
europepmc +1 more source
Facial Melanosis: A Comprehensive Review of Uncommon and Common Presentations with Personal Experience. [PDF]
Sarkar R, Verma D.
europepmc +1 more source

